MSF Attacks Vaccines Collaboration Over ‘Toothless’ New Equitable Access Policy
The Coalition for Epidemic Preparedness Innovationhas come under attack from Médecins sans Frontières over its revised equitable vaccines access policy, which the NGO claims has been watered down at the behest of the pharmaceutical industry.
You may also be interested in...
Plans to have candidate vaccines ready for testing against infectious diseases during an evolving epidemic have taken a step forward with the announcement of a partnership between CEPI, the global fund supported by governments and philanthropists, and the vaccine-focused European biotech, Themis Bioscience.
New guidance from the UK covers the recognition of EU approvals, accelerated assessment, rolling reviews, and much else besides.
As negotiations between the UK and EU enter a crucial phase, the UK life sciences industry has called for more clarity and guidance on what companies can expect to face at the end of the Brexit transition period.